- Home
- LPCN vs YQ Comparison
LPCN vs YQ Comparison
Compare LPCN & YQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPCN | YQ |
|---|---|---|
| Founded | 1997 | 2012 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.7M | 22.2M |
| IPO Year | 2011 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LPCN | YQ |
|---|---|---|
| Price | $2.10 | $3.82 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 31.2K | ★ 68.5K |
| Earning Date | 05-07-2026 | 06-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,976,677.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $92.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.81 | $1.68 |
| 52 Week High | $12.37 | $6.45 |
Technical Indicators
Market Signals| Indicator | LPCN | YQ |
|---|---|---|
| Relative Strength Index (RSI) | 38.84 | 59.51 |
| Support Level | $2.00 | $3.26 |
| Resistance Level | $2.27 | $4.59 |
| Average True Range (ATR) | 0.09 | 0.41 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 0.00 | 42.04 |
Price Performance
Historical ComparisonAbout LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About YQ 17 Education & Technology Group Inc.
17 Education & Technology Group Inc is engaged in providing education and education technology services in the People's Republic of China (PRC) with a focus on the Teaching and Learning SaaS offerings. It offers smart, in-school, teaching and learning SaaS offerings assist students, teachers, schoolmasters and educational authorities across China. It also offer other educational products and services that complement students' in-school learning. Geographically group operates in China.